한국임상약학회지 (Korean Journal of Clinical Pharmacy)
- 제3권1호
- /
- Pages.45-53
- /
- 1993
- /
- 1226-6051(pISSN)
- /
- 2508-786X(eISSN)
Biphenyl Dimethyl Dicarboxylate의 저용량 단기 투여가 만성 간염환자의 상승된 Aspartate Aminotransferase와 Alanine Aminotransferase의 저하 효과에 관한 임상적 연구
Clinical Study for Low Dose & Short-Term Therapy of Biphenyl Dimethyl Dicarboxylate(DDB) in the Chronic Hepatitis. Patients with Elevated Serum Aspartate Aminotransferase and Alanine Aminotransferase Levels
-
Kim, Dong Woung
(Wankvvang Medical Center, Wonkwang University) ;
- Kang, Byung Ki (Wankvvang Medical Center, Wonkwang University)
- 발행 : 1993.06.01
초록
Biphenyl Dimethyl dicarboxylate(DDB) has been regarded as a safe, effective drug for decreasing serum aminotransferase levels from elevated serum aminotransferase levels, which cause acute or chronic hepatitis and chronic liver diseases. This study was designed to low dose(22.5mg/day) & short-term therapy effectiveness for 4 weeks of DDB in 30 chronic hepatitis patients with elevated serum aminotransferases. The following results were observed. 1. Serum alanine aminotransferase(ALT) levels significantly decresed from 173.
키워드